BIO Opposes Flawed Maryland House Bill

Patrick Plues, BIO’s Vice President, State Government Affairs, testified before the Maryland House in opposition to House Bill 666, which endangers innovation and fails to achieve the objective of lowering healthcare costs. Read Patrick’s testimony here.
In advance of the hearing, two prominent leaders within Maryland’s bioscience industry expressed their opposition to the flawed bill in an op-ed that ran in The Baltimore Sun.